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Recent evidence suggests that mononuclear cells (MNCs) derived from bone marrow and cord blood can differentiate into
mesenchymal stem cells (MSCs) or outgrowth endothelial cells (OECs). However, controversy exists as to whether MNCs have the
pluripotent capacity to differentiate into MSCs or OECs or are a mixture of cell lineage-determined progenitors of MSCs or OECs.
Here, using CD133+/C-kit+/Lin− mononuclear cells (CKL− cells) isolated from human umbilical cord blood using magnetic cell
sorting, we characterized the potency of MNC differentiation. We first found that CKL− cells cultured with conditioned medium
of OECs or MSCs differentiated into OECs or MSCs and this differentiation was also induced by cell-to-cell contact. When we
cultured single CKL− cells on OEC- or MSC-conditioned medium, the cells differentiated morphologically and genetically into
OEC- orMSC-like cells, respectively. Moreover, we confirmed that OECs orMSCs differentiated fromCKL− cells had the ability to
form capillary-like structures inMatrigel and differentiate into osteoblasts, chondrocytes, and adipocytes. Finally, usingmicroarray
analysis, we identified specific factors of OECs or MSCs that could potentially be involved in the differentiation fate of CKL− cells.
Together, these results suggest that cord blood-derived CKL− cells possess at least bipotential differentiation capacity towardMSCs
or OECs.
1. Introduction
Stem cells are a current focus of scientific research due to
their plasticity and extensive self-renewal capacity and ability
to differentiate into one or more committed descendants,
including fully functional mature cells [1]. Stem cells can
differentiate into many cell types, such as cardiomyocytes,
vascular cells, neurons, and hepatocytes, both in vitro and
in vivo. For this reason, regenerative medicine has become a
potential therapy for degenerative diseases such as myocar-
dial infarction, vascular diseases, motor neuron diseases,
neurodegenerative diseases, and liver disease [2–7]. Classified
according to their origin, stem cells may be embryonic
stem cells, tissue-specific stem cells, mesenchymal stem cells
(MSCs), or induced pluripotent stem cells. Because the use
of embryonic stem cells is restricted due to ethical concerns,
tissue-specific stem cells, MSCs, and induced pluripotent
stem cells are the main cell types for tissue engineering.
Umbilical cord blood stem cells can differentiate into
endothelial cells or MSCs in vitro and in vivo and improve
poorly functioning organs [8–10]. Two types of endothelial
cells cultured from human peripheral blood, endothelial
progenitor cells and outgrowth endothelial cells (OECs),
show comparable angiogenic capabilities [11]. OECs have out-
growth potential and may potentially be used for angiogenic
therapies via transplantationwith endothelial progenitor cells
[12, 13]. Although MSCs are capable of differentiating into
cells of different connective tissue lineages, such as bone,
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cartilage, and adipose tissue [10], themechanisms underlying
the differentiation of stem cells derived from human cord
blood into MSCs or OECs are not fully understood.
To determine whether cord blood-derived mononuclear
cells (MNCs) have the ability to differentiate into MSCs
or OECs or are a mixture of cells containing cell lineage-
determined progenitors of MSCs or OECs, we characterized
the differentiation potency of CD133+/C-kit+Lin− MNCs
(CKL− cells) isolated from human umbilical cord blood
using magnetic activated cell sorting. When CKL− cells
were cultured on MSC- or OEC-conditioned medium, they
preferred to differentiate into MSCs or OECs, respectively.
Direct coculture of CKL− cells with OECs or MSCs also
induced their differentiation into OECs or MSCs, which had
the ability to form capillary-like structures in Matrigel or
to differentiate into osteoblasts, chondrocytes, or adipocytes.
Moreover, using microarray analysis, we identified the spe-
cific factors of OECs and MSCs that could direct the cell fate
of CKL− cells.
2. Materials and Methods
2.1. Study Population and Sample Collection. Of the deliveries
at our institute between June 2007 and March 2008, only
those performed by cesarean section at 37–41 weeks of
gestation were included in this study. Umbilical cord blood
for CKL− cell isolation was obtained at the time of delivery
after fetal expulsion. Pregnancies associated with premature
rupture of membranes, fetal malformation, chromosome
anomaly, multiple pregnancies, preeclampsia, hypertension,
or renal or endocrine diseases were excluded from the
study. The sampling and use of medical records for research
purposes were performed with the consent of patients. This
study was approved by the Yonsei University Hospital Review
Board (4-2005-0186).
2.2. Isolation and Cultivation of CKL− Cells. We isolated en-
dothelial progenitor cells from human umbilical cord blood.
Blood samples (∼50mL each) were collected from fresh
placentas with attached umbilical cords by gravity flow.
MNCs were isolated by density gradient centrifugation
over Biocoll (Biochrom, Berlin, Germany) for 30min at
400×g and washed three times in phosphate buffered saline
(PBS) (Biochrom). CKL− cells were purified by positive and
negative selection with anti-CD133/C-kit/Lin− microbeads
(Miltenyi Biotec, Bergisch-Gladbach, Germany) using amag-
netic cell sorter device (Miltenyi Biotec). Briefly, cord blood
MNCs were incubated with anti-CD133 microbeads and
unbounded antibodies were removed by cell washing. Cells
incubated with anti-CD133 microbeads were processed for
positive selection, according to the manufacturer’s instruc-
tions. CD133+ fraction was then incubated with anti-C-
kit microbeads and processed for running sensitive positive
selection. For depletion of Lin+ cells from CD133+/C-kit+
fractions, cells were incubated with anti-Lin microbeads and
applied on column. Unbound cells were washed out and
collected. This fraction is CD133+/C-kit+/Lin−. Purity, as
assessed by fluorescence activated cell sorting analysis, was
>98%. CKL− cells were seeded onto 6-well plates coated with
human fibronectin (Sigma, St. Louis, MO) in endothelial
basal medium-2 (Clonetics, Cell Systems, St. Katharinen,
Germany). The medium was supplemented with endothelial
growthmedium-2 (EGM-2; Clonetics, Cell Systems) contain-
ing fetal bovine serum, human VEGF-A, human fibroblast
growth factor-B, human epidermal growth factor, IGF1, and
ascorbic acid in appropriate amounts. CKL− cell identifica-
tion was determined by staining cells with phycoerythrin-
(PE-) conjugated human antibodies CD133-PE and C-kit-PE
(BD Biosciences, Bedford, MA).
2.3. CKL− Cell Differentiation Assay. CKL− cells (5 × 105
cells/well) were seeded on 6-well plates and cultured in
OEC- orMSC-conditionedmedium (100% EGM-2 (control),
12.5% conditionedmedium+87.5%EGM-2, 25% conditioned
medium + 75% EGM-2, or 50% conditioned medium + 50%
EGM-2). The medium was changed every 2 days. The day
of differentiation was defined as the first day on which a
differentiated colony was observed from the time of seeding.
At least three assays were performed for each sample.
CKL− cells were cocultured with green fluorescent
protein- (GFP−) transfected OECs or MSCs. After 3 days in
culture, GFP− OECs or MSCs began to appear among GFP+
OECs or MSCs. GFP− OECs and MSCs differentiated from
CKL− cells were confirmed by immunofluorescent staining
for VE-cad antibody and alpha-smooth muscle actin (𝛼-
SMA), respectively.
After 5 days in culture, CKL− cells were harvested, diluted
in cell culture medium to approximately 1 cell/100 𝜇L, and
replated in 96-well cell culture plates. After 24 hours, the
culture medium was changed to OEC- or MSC-conditioned
medium (50%). On day 4, differentiated cells were defined
and further expanded in 24-well, 60mm plates until cell
numbers were sufficient for immunostaining analyses. At
least three assays were performed for each sample.
2.4. Semiquantitative RT-PCR Analysis. Total RNA was ob-
tained from CKL− cells, OECs, and MSCs with TRIzol
reagent. RNA samples (0.5–5 𝜇g) were used for RT-PCR.
Briefly, target RNA was converted to cDNA by treatment
with 200 units of reverse transcriptase and 500 ng oligo(dT)
primer in 50mM Tris-HCl (pH 8.3), 75mM KCl, 3mM
MgCl
2
, 10mM dithiothreitol, and 1mM dNTPs for 1 h at
42∘C. The reaction was quenched by heating for 15min at
70∘C. One 𝜇L of the cDNAmixture was used for PCR ampli-
fication. PCR reactions contained 50mM KCl, 10mM Tris-
HCl (pH 8.3), 1.5mM MgCl
2
, 0.2mM dNTPs, 2.5 units of
Taq DNA polymerase, and 0.1 𝜇M of primers. Amplification
was performed in a model PTC-200 thermal cycler under the
following conditions: denaturation at 94∘C for 5min for the
first cycle and for 30 s thereafter, annealing for 30 s at 55∘C,
and extension for 30 s at 72∘C for 28 repetitive cycles. A final
extension step proceeded for 10min at 72∘C. Each experi-
ment was performed in quadruplicate. The primers used are
described in Supplementary Table S1 in SupplementaryMate-
rial available online at http://dx.doi.org/10.1155/2016/7162160.
2.5. Immunofluorescence Staining of CKL− Cells, OECs, and
MSCs. Cells were fixed in 4% paraformaldehyde for 20min,
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permeabilized in 0.1% Triton X-100/PBS, and then prein-
cubated with blocking solution consisting of PBS con-
taining 5% normal goat serum and 0.05% Tween-20.
Cells were then incubated for 2 h in primary antibody
[mouse anti-CD133, anti-C-kit, anti-vWF, anti-CDH5 (VE-
cadherin), anti-𝛼-SMA, or anti-PDGFR𝛽 (BD Pharmingen,
San Diego, CA)]. Reactions were visualized by FITC/TRITC-
conjugated anti-human secondary antibody (Vector Labora-
tories, Burlingame, CA). All samples were observed with a
fluorescence microscope (Olympus, Tokyo, Japan).
2.6. Osteogenesis Assay. ConfluentMSCswere cultured for 10
days in DMEM low-glucose medium with 10% fetal bovine
serum, 1x GPS, and osteogenic supplements (1𝜇M dex-
amethasone, 10mM 𝛽-glycerophosphate, and 60 𝜇M ascor-
bic acid-2-phosphate). Differentiation into osteocytes was
assessed by von Kossa staining.
2.7. Chondrogenesis Assay. Suspensions of MSCs were trans-
ferred into 15mL polypropylene centrifuge tubes (500,000
cells/tube) and gently centrifuged. The resulting pellets were
statically cultured in DMEM high-glucose medium with 1x
GPS and chondrogenic supplements (1x insulin-transferrin-
selenium, 1 𝜇M dexamethasone, 100 𝜇M ascorbic acid-2-
phosphate, and 10 ng/mL TGF-𝛽1). After 14 days, pellets were
fixed in 4% buffered formalin overnight, embedded in paraf-
fin, and sectioned (7 𝜇m). Differentiation into chondrocytes
was assessed by safranin-O staining.
2.8. Adipogenesis Assay. Confluent MPCs were cultured for
10 days in DMEM low-glucose medium with 10% FBS, 1x
GPS, and adipogenic supplements (5𝜇g/mL insulin, 1 𝜇M
dexamethasone, 0.5mM isobutylmethylxanthine, and 60𝜇M
indomethacin). Differentiation into adipocytes was assessed
by Oil Red O staining.
2.9. Oligonucleotide Microarrays. Total RNA (10 𝜇g) was
hybridized to the HG-U133A 2.0 microarray (54675 human
genes; Affymetrix, Santa Clara, CA) following the man-
ufacturer’s standard protocol for sample preparation and
microarray processing. Expression data were analyzed using
Microarray Suite version 5.0 (Affymetrix) and GenPlex v2.4
software (ISTECH Inc., Seoul, Republic of Korea).
2.10. Statistical Analyses. Data are shown as mean ± standard
error (SE). Statistical comparisons between groups were
performed using one-way analysis of variance followed by
Tukey’s post hoc tests.
3. Results
3.1. Differentiation of Human Cord Blood-Derived CKL− Cells
into OECs or MSCs. The MNC fraction was separated from
cord blood using density gradient, and CKL− MNCs were
sorted and purified (Figure 1(a)). The cellular phenotype of
CKL− cells was confirmed by RT-PCR and immunostaining
for CD133 and C-kit (Figure 1(b)). After 10 days in OECs or
MSCs differentiation culture condition, CKL− cells sponta-
neously differentiated into OECs or MSCs as confirmed by
cell morphology and expression of lineage-specific markers
(Figures 1(c) and 1(d)).
3.2. CKL− Cells Have Multilineage Differentiation Potential
Depending on Environmental Factors. To investigate whether
the environment regulates CKL− cell differentiation, CKL−
cells were cocultured with GFP+ OEC or MSCs. Double
labeling of OEC or MSC with GFP and CKL− cells with RFP
is ideal experiment model; however, GFP or RFP-infection
into CKL− cells induced significant detachment of CKL−
cells from plate and we were unable to proceed with the
experiment. Therefore, we only labeled the OEC or MSC
with GFP− lentivirus and cocultured with nonlabeled CKL−
cells. CKL− cells differentiated into the same cell lineage
as the cells with which they were cocultured as confirmed
by immunofluorescence staining for cell-specific markers
(Figures 2(a) and 2(b)). These results indicate that the local
environment determines the differentiation specification of
CKL− cells.
Next, CKL− cells were cultured on OEC- or MSC-
conditioned medium in a dose-dependent manner to evalu-
ate the effect of soluble factors on differentiation. The length
of time to achieve differentiation was significantly reduced
in CKL− cells cultured on conditioned medium compared
with the control condition, suggesting that soluble factors
produced by OECs or MSCs accelerate CKL− cell differen-
tiation (Figures 3(a) and 3(b)). Moreover, GFP+ CKL− cells
cocultured with OECs or MSCs differentiated into OECs or
MSCs as confirmed by immunofluorescence staining for VE-
cadherin or 𝛼-SMA, respectively (Figures 3(c) and 3(d)).
CKL− cells did not proliferate in in vitro culture condi-
tions. Therefore, to further determine whether CKL− cells
have the potential to differentiate into multiple lineages
depending on environmental cues or are a mixture of cells
with monolineage differentiation potential toward OECs or
MSCs, single GFP+ CKL− cells were cultured on OEC- or
MSC-conditioned medium (Figures 4(a) and 4(c)). On day
4, 93.2% of cells cultured on OEC-conditioned medium and
97.4% of cells cultured on MSC-conditioned medium exhib-
ited OEC and MSC phenotypes, respectively (Figure 4(e)).
The phenotype of differentiated GFP+ OECs or MSCs was
confirmed by immunofluorescence staining for VE-cadherin
or 𝛼-SMA, respectively (Figures 4(b) and 4(d)). It is well
known that lentivirus integrates into host cell genome and
is maintained for a long time. Therefore many researchers
use GFP− lentivirus for cell tracing. However, cells can lose
lentivirus GFP− fluorescence during over multiple passages.
In our experiment, differentiated GFP+ single cells were
expanded until cell numbers were sufficient for immunos-
taining, during which some cells lost GFP. Therefore, some
GFP negative cells are present among the GFP positive cells
(Figures 4(b) and 4(d)).
Based on these results,maximum93.2% (=93.2%∩97.4%)
of CKL− cells have bilineage differentiation potential. As
a result, CKL− cells had the potential to differentiate into
bothOECs andMSCs (Figure 4(e)). Collectively, these results
suggest that CKL− cells have multilineage differentiation
potential depending on environmental factors.
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Figure 1: Isolation and characterization of CKL− cells from human umbilical cord blood. (a) CKL− cells were isolated by density gradient
centrifugation over Biocoll for 30min at 400×g, washed three times in PBS, and purified by positive selection with anti-CD133/C-kit/Lin−
microbeads using a magnetic cell sorter device. (b) Total mRNAwas isolated from CKL− cells, and gene expression was assessed by RT-PCR.
CKL− cells were further characterized by immunofluorescent staining for CD133 and C-Kit. (c, d) CKL− cells differentiated into OECs and
MSCs as confirmed by RT-PCR and immunofluorescent staining for OEC- and MSC-specific markers.
3.3. Functional Characterization of OECs and MSCs Differ-
entiated from CKL− Cells. Progenitor cells are defined and
distinguished by their clonogenic and proliferative potential.
We analyzed the proliferative kinetics of OECs and MSCs
derived from CKL− cells. We initially plated single OECs or
MSCs differentiated from CKL− cells to test whether they
would form a colony and grow to confluence. Interestingly,
the cell progeny of single OECs or MSCs formed colonies of
various sizes before growing to confluence (Figures 5(a) and
5(b)).
We next tested whether the OECs derived from CKL−
cells could incorporate Dil-acetylated low-density lipopro-
tein (Dil-Ac-LDL) and form capillary-like structures in
Matrigel, which is characteristic of endothelial cells. Images
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Figure 2: The microenvironment induces the differentiation of CKL− cells into OECs or MSCs. (a) CKL− cells were cocultured with GFP−
transfected OECs or MSCs. After 3 days in culture, GFP− OECs or MSCs began to appear among GFP+OECs or MSCs cells, respectively
(arrowheads). (b) GFP− OECs and MSCs differentiated from CKL− cells were confirmed by immunofluorescent staining for VE-cad and
𝛼-SMA antibody, respectively.
of OECs differentiated from adherent CKL− cells show the
uniform incorporation of Dil-Ac-LDL and the formation of
capillary-like structures in Matrigel, similar to blood vessel
endothelial cells (Figure 6(a)).
Next, the osteogenic potential of MSCs derived from
CKL− cells was assessed by culturing cells under optimal
conditions for inducing osteogenic differentiation. When
differentiated under osteogenic conditions, the spindle shape
of MSCs derived from CKL− cells flattened, broadened,
and formed a mineralized matrix as shown by von Kossa
staining (Figure 6(b), left panel). An osteoblastic phenotype
was also evidenced by the expression ofmarker genes alkaline
phosphatase (ALP), osteocalcin (OC), osteopontin (OP),
runt-related transcription factor 2 (CBFA1:CF), and type I
collagen (Col I) (Figure 6(c), left panel).
Furthermore, the chondrogenic potential of MSCs
derived from CKL− cells was examined by the pelleted
micromass system in serum-free chondrogenic medium.
After 2 weeks of differentiation, the accumulation of
sulfated proteoglycans was visualized by safranin-O staining
(Figure 6(b), middle panel). Expression of mRNA for
aggrecan (AGC), type II collagen (Col II), type IX collagen
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Figure 3: Soluble factors generated from OECs or MSCs accelerate CKL− cell differentiation. (a) CKL− cells were cultured in OEC- or
MSC-conditioned medium in a dose-dependent manner (0, 12.5, 25, or 50%). (b)The day of differentiation, defined as the first day on which
differentiated colonies were observed from the time of seeding, occurred significantly sooner in CKL− cells differentiated in conditioned
mediumcomparedwith control conditions. ∗∗𝑝 < 0.01 versus control. (c)GFP+CKL− cells were coculturedwithOECs orMSCs.Arrowheads
indicate morphologically differentiated GFP+OECs or MSCs. (d) OECs or MSCs differentiated from GFP+CKL− cells were characterized by
immunofluorescent staining using VE-cad or 𝛼-SMA antibody, respectively.
(Col IX), and Sox9 (S9), which are marker genes for
chondrocytes, was detected by RT-PCR after 14 days of
induction (Figure 6(c), middle panel).
Finally, CKL− cells were cultured in adipogenic medium
to assess the potential of MSCs to become adipocytes. Mor-
phologic changes and the formation of neutral lipid vacuoles
were visualized by staining with Oil Red O (Figure 6(b),
right panel). An adipogenic phenotype was also detected
by the expression of marker genes lipoprotein lipase (LPL),
CCAAT/enhancer-binding protein alpha (C/EBP𝛼), peroxi-
some proliferator-activated receptor gamma (PPAR𝛾), leptin,
and adipocyte P2 (aP2) (Figure 6(c), right panel).
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Figure 4: CKL− cells have multilineage differentiation potential depending on environmental factors. (a, c) Single GFP+ CKL− cells were on
OEC- or MSC-conditioned medium. (e) The differentiation efficiency of CKL− cells into OECs and MSCs on day 4 was 93.22% and 97.37%,
respectively. (b, d) The phenotype of differentiated GFP+OECs or MSCs was confirmed by immunofluorescent staining for VE-cadherin or
𝛼-SMA antibody, respectively.
3.4. Cell-SpecificMolecules Regulate CKL−Cell Differentiation
toward OECs or MSCs. As CKL− cell differentiation fate was
determined by the conditioned medium in which cells were
cultured, we hypothesized that paracrine/endocrine factors
provided by OECs and MSCs are involved in driving the
differentiation of CKL− cells into specific lineages. To address
this, we performed comparative analysis of gene expression
between OECs and MSCs to identify cell-specific expression
of genes encoding soluble factors. Genes expressed more
highly in OECs were Jagged 1 (JAG1), JAG2, placental growth
factor (PGF), endothelial cell-specific molecule 1 (ESM1),
neurite growth-promoting factor 2 (MDK), inhibin beta A
(INHBA), growth differentiation factor-3 (GDF3), pre-B-cell
colony-enhancing factor 1 (PBEF1), endothelin 1 (EDN1),
interleukin 32 (IL32), heparin-binding EGF-like growth fac-
tor (HBEGF), chemokine (C-X-C motif) ligand 1 (CXCL1),
chemokine (C-C motif) ligand 2 (CCL2), CCL14, CCL15,
bone morphogenetic protein 2 (BMP2), BMP4, and BMP6,
whereas genes expressedmore highly inMSCswerewingless-
type MMTV integration site family, member 5A (WNT5A),
CXCL5, vascular endothelial growth factor (VEGF), CCL20,
angiopoietin 1 (ANGPT1), growth differentiation factor 5
(GDF5), and WNT5B (Figure 7). Thus, these cell-specific
factors secreted in the microenvironment may direct CKL−
cell differentiation toward specific lineages.
4. Discussion
The primary source of stem or progenitor cells for research
purposes has shifted from bone marrow to umbilical cord
blood, which is easily accessible, does not involve invasive
procedures for collection, can be stored for longer durations,
and is immune-tolerant. Although once a discardedmaterial,
umbilical cord blood is now considered an alternative source
for stem/progenitor cell transplantation and therapy due to
its hematopoietic and mesenchymal components [14–17].
However, the yield of progenitor cells of interest from cord
blood samples is variable and often unsatisfactory, limiting
their therapeutic use. To overcome this hurdle, a better
understanding of the primitive cell population in umbilical
cord blood is imperative for optimizing cell expansion.
Furthermore, although the differentiation capacity of cord
blood MNCs has been extensively studied [18–20], little is
known about whether MNCs have the pluripotent capacity
to differentiate into MSCs or OECs or are a mixture of
progenitor cells with determined MSC or OEC fates.
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Figure 5: Representative colony formation assay of OECs or MSCs derived from CKL− cells. (a, b) Single OECs or MSCs differentiated from
CKL− cells were cultured, and cell growth was analyzed at each time point. Arrowheads indicate the boundary of colonies.
Previous studies report that adult peripheral blood and
cord blood CKL− MNCs can give rise to MSCs and OECs
[8, 21–26]. Consistently, we found that CLK- MNCs puri-
fied from cord blood were able to differentiate into both
MSCs and OECs with demonstrable biological in vitro and
in vivo function. The differentiation fate of CKL− MNCs
largely depended on the type of cells with which MNCs
were cocultured or from which conditioned medium was
collected. These findings suggest that environmental factors,
such as cell-to-cell contact or soluble factors secreted from
surrounding cells, direct the differentiation of CKL− cells.
Furthermore, to determine whether CKL− MNCs are a
mixture of MSC and OEC progenitors or have multipotent
differentiation capacity toward OECs or MSCs depending on
the in vivo milieu, we cultured single CKL− cells in either
MSC- or OEC-derived conditioned medium. We found that
CKL− MNCs have bipotential ability to generate MSCs and
OECs, most likely due to the influence of environmental
factors.
Various cues within the microenvironment such as cell-
cell contact, mechanical forces, soluble factors, and extra-
cellular interactions are involved in the fate-determination
steps of stem cells [27–30]. To date, however, soluble factors
that contribute to lineage-specific differentiation of CKL−
cells are not well studied. As we found that CKL− MNC
differentiation depended on environmental factors such as
the presence of specific cell types or conditioned medium,
we hypothesized that soluble factor genes highly expressed
in MSCs or OECs could determine CKL− cell differentiation
fate. Based on gene expression profiling, we found that
MSCs showed high gene expression of WNT5A, CXCL5,
VEGF, CCL20, ANGPT1, GDF5, andWNT5B, whereasOECs
showed high gene expression of JAG1, JAG2, PGF, ESM1,
MDK, INHBA, GDF3, PBEF1, EDN1, IL32, HBEGF, CXCL1,
CCL2, CCL14, CCL15, BMP2, BMP4, and BMP6. Likewise,
others have reported the upregulation of PGF [31], ESM1 [32],
GDF3 [33], CXCL1 [34], BMP2, and BMP4 [35] in cord blood
OECs. Previous studies also show that MSCs secrete VEGF
to promote differentiation of neuronal precursors [36, 37]
and CCL20 to modulate immune response [38, 39]. JAG1 and
JAG2, which are NOTCH ligands, are known to play a pivotal
role in the angiogenesis of various organs and injured arteries
[40–44]. Furthermore, we recently showed that the expres-
sion of endothelial genes Delta-like 1 (DLL1) and JAG1 is
closely related to the differentiation and angiogenic function
of CKL− cells [8]. Nonetheless, while these specific genes for
secreted factors identified may direct differentiation, it is also
likely that these gene expressions are the result and not the
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Figure 6: Functional characterization of OECs and MSCs. (a) Imaging of Dil-Ac-LDL-labeled OECs cultured on Matrigel-coated wells
demonstrating capillary-like structure formation. (b) After incubation for 2-3 weeks in each differentiation medium,MSCs stained positively
for calcium deposition (von Kossa staining), chondrocyte matrix (safranin-O staining), and lipid vacuoles (Oil Red O staining), indicating
osteogenic, chondrogenic, and adipogenic differentiation, respectively. (c) Total mRNA was isolated from osteoblasts, chondrocytes, and
adipocytes, and specific marker gene expression profiles were assessed by RT-PCR. OB: osteoblast, CD: chondrocyte, and AD: adipocyte.
cause of the differentiation.Therefore, further investigation is
needed to confirm their role and mechanisms by which these
molecules regulate lineage-specific differentiation.
In conclusion, CKL− MNCs in umbilical cord blood
possess the ability to differentiate into MSC and OEC
lineages depending on specific microenvironmental factors.
This result suggests that CKL−MNCs are excellent sources of
EC and MSC for the tissue regeneration.
5. Conclusions
This study demonstrates that human umbilical cord blood-
derived CKL− cells can differentiate into OECs or MSCs and
have multilineage differentiation potential. The microenvi-
ronment induces the differentiation of CKL− cells into OECs
or MSCs and soluble factors generated from OECs or MSCs
accelerate CKL− cell differentiation. Our data reveals the
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Figure 7: CKL− cell fate may be determined by specific molecules. Gene expression profiles were analyzed and compared between OECs and
MSCs, and cell-specific upregulated genes are shown.
tremendous potential of CKL−MNCs as excellent sources of
EC and MSC for the tissue regeneration.
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